Verastem | VSTM - Capital Ordinário





Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Alaunos Therapeutics USD 2.21M 131K 2025-09
AstraZeneca USD 1.55B 73K 2026-03
Curis USD 12.93M 12.87M 2025-12
Cytokinetics USD 124.43M 2.17M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-03
Incyte USD 199.95M 1.49M 2026-03
Laboratory Of America USD 82.3M 100K 2026-03
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.7B 13M 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
TG Therapeutics USD 155.31M 95K 2025-12
Verastem USD 77.74M 77.74M 2025-12